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Stochastic Simulation of Clinical Pathways from Raw Health Databases
Martin Prodel2, Vincent Augusto1, Xiaolan Xie1,3, Baptiste Jouaneton2 and Ludovic Lamarsalle2
Abstract—This paper presents a method to automatically
create stochastic simulation models of clinical pathways from
raw databases. We introduce an automatic procedure to convert
a process model, discovered with process mining, into an
actionable simulation model. The concept of state charts is used
and enriched to incorporate the distinctive features of health-
care processes into the model. The clinical pathway model is
used to simulate new patients’ sequence of events. The resulting
model is validated by comparing key performances indicators
with historical data. Finally, we use the model to perform an
automatically setup sensitivity analysis. The whole process is
automated and can be used with any input data.
I. INTRODUCTION
Clinical Pathways (CP) are a collection of activities that
serve a common goal, such as consultation, rehabilitation
or chemotherapy sessions. A CP describes the whole care
journey of a patient across various health-care structures.
Data related to CP are collected in hospitals for various
purpose: in France, the national hospitalization database is
primarily used for the pricing of care activities in hospitals,
but it also contains a large amount of valuable data about
the patient, his/her pathology and treatment.
The study of such data is important to reveal patterns of
CP and a better understanding of the processes and of its
potential improvements through new treatments, medicines,
or medical devices. Health authorities intend to propose
standardization of care processes for various operational pur-
poses: organization of care activities, assignment of human
resources, reducing practice variability, minimizing delays
in treatments or decreasing costs while maintaining quality.
Today, there is a will to go further than experts’ opinions to
answer these challenges. As such, evidence-based medicine
has become paramount to medical decision making and
clinical judgment.
The work presented in this paper is the last part of a large
study consisting in applying a combination of data analysis
and process mining [1] to build automatically a model of a
CP for a certain cohort of patients. The reader is referred to
[2] and [3] for further details about the automatic generation
of CP models and conversion into simulation models. The
goal of the present study consists in providing a “simulation
toolbox” that can be used by health-care practitioners to learn
about available health databases.
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Most simulation models are handmade: the perception of
the actual process is inﬂuenced by the modeler’s experience,
creating modeling biases. To avoid such biases, the idea of
integrating process mining results to automatically generate
a complete simulation model was initiated by [4] and was
taken over by [5] and [6]. In [4], the focus is on the
simulation model validation (whether generated or hand-
made) to ensure sufﬁcient quality of simulation results. The
authors also highlight the challenges of automatic discovery
of simulation models from event logs, including creating not
too complex models, adding other perspectives to the ﬂow
perspective and adjusting the model for real-time simulation.
An example is shown using Petri Net as the representation
of their process models. Concerning Sensitivity Analysis
(SA), it is the study of how input variations induce output
modiﬁcations. SA is either local or global [7]. Local SA
study the variations of a single parameter while other pa-
rameters remain ﬁxed [8], and global SA study the output
changes when all the parameters vary simultaneously [8].
However, such approaches are never automated, is also time-
consuming and subject to bias. In this paper, we propose an
automated approach to perform a sensitivity analysis on a
model discovered from raw health databases. It allows to
determine data variables which have the highest impact on
considered key performance indicators (KPI).
The scientiﬁc contribution of this paper is twofold: (i) an
automated stochastic simulation of clinical pathways directly
connected to a raw health database; (ii) a method to analyze
and discuss KPI for the health-care area through automated
SA. A new validation procedure is proposed to assess the
results on a real case study. CP analysis is performed using
an automatic sensitivity analysis, taking into account the
characteristics of the health data recorded in database. An
extension to a formal sub-class of state-charts is also
provided to take into account all special features of CPs.
The paper is organized as follows. The global methodol-
ogy is described in Section II. The state chart formalism used
to simulate discovered CP is detailed in Section III. The CP
stochastic simulation toolbox is provided in Section IV. A
case study is proposed in Section V. Finally, conclusions and
perspectives are given in Section VI.
II. METHODOLOGY
In a previous work [2], we proposed a new approach to
discover Clinical Pathways (CP) from the French national
hospitalization database using process mining. The objective
was to create the most representative process model of an
event log under a constraint on the size of the model. In the
literature, CP analysis from raw data was mainly done with
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data mining or process mining techniques, both receiving an
increasing attention in medical informatics. The next step
of this research, consists in proposing a model that can
be executed using simulation and automatically analyzed
regarding relevant KPI.
This paper provides a comprehensive methodology to
analyze and simulate such CPs as described in Figure 1. It
uses an existing process model discovered from an event log
(step 1) [2], a set of features found using health-care data
analytics tools (step 2) [9] and a set statistical distributions
(step 3). For that, we propose (i) a new procedure to
automatically build a simulation model of patient CP from
an event log of hospital stays, and (ii) a new subclass of
state charts called “Clinical Pathway State Charts” (CPSC)
to capture all the required material to efﬁciently simulate
and evaluate the performances of any CP. This subclass is
an extension of the one proposed in [3] to include health-care
decision point analysis. A simulation procedure is proposed
to perform automatic analysis (step 4). Such methodology
may be applied to any database and any cohort of patients.
Simulation of CPs brings new knowledge and allows scenario
evaluation through design of experiments.
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Fig. 1. Global scheme of our automatic modeling methodology
III. A SUBCLASS OF STATE CHARTS: CLINICAL
PATHWAY STATE CHART
To simulate the clinical pathway of new patients, we
use the general concept of state charts. It includes the
deﬁnition of states, transitions, activation probabilities and
state duration. We enrich this state chart deﬁnition with two
new concepts: wait-states and care-states. Eventually, we
introduce a new subclass of state chart that encapsulates all
the speciﬁc features of a CP and simulates it.
Deﬁnition 1 (State chart): A state chart (SC) is a 4-tuple
M = (S, V, ζ, τ) where S = {s1, s2, . . . , sn} is a ﬁnite
set of states, V ⊆ (S × S) is a ﬁnite set of transitions,
ζ : V → [0, 1] is the probability of activating a transition,
and τ : S → N is the time spent in a state.
We use state charts to model patient CPs. A patient is
modeled using the concept of entity, deﬁned by a set of
features and an active state.
Deﬁnition 2 (Entity): An entity is a 3-tuple u = (M,f, s),
where M = (S, V, ζ, τ) is a SC, f = {f1(u), ..., fx(u)}) is a
set of assigned values for attributes from F (the set of trace’s
attributes) and s is its current state, s ∈ S.
Two types of states are deﬁned to distinguish states related
to hospital stays from states related to waiting periods
between two stays.
Deﬁnition 3 (Care-state): A Care-state is a 2-tuple
sc = (l, B) where l is a unique label and B =
{(f1, v1), . . . , (fn, vn)} is the list of entities’ features
{f1, ..., fn} to be updated in this state with new values
{v1, ..., vn}, (n ∈ N
∗). B includes at least a state-related
cost that is used as a simulation performance indicator.
Deﬁnition 4 (Wait-state): A wait-state is a singleton sw =
(l) where l is a unique label.
A care-state is related to a change in a patient’s health
condition and requires a medical response process during
which the entity’s attributes may change according to B.
Finally, we propose a new subclass of state chart to describe
clinical pathways, denoted Clinical Pathway State Chart.
Deﬁnition 5 (Clinical Pathway State Chart): A Clinical
Pathway State Chart is a 6-tuple CPSC = (S, V, ζ, τ, p, q):
1) S = Sw ∪ Sc where Sw is a ﬁnite set of wait-states
and Sc is a ﬁnite set of care-states
2) V ⊆ (Sc × Sw) ∪ (Sw × Sc) is the set of transitions
(vertexes) of the CPSC
3) ζ gives the probability of activating each transition
given a state s and a set of features F = {f1, ..., fx}:
ζ : S × F → V |V | × [0, 1]|V |
s× {f1, ..., fx} → (vi, pi)
4) τ : S → N is the time spent in a state.
5) p : S → [0, 1] is the probability that the simulation
starts at a given care-state,
∑
s∈S
p(s) = 1
6) q : S → [0, 1] is the probability that the simulation
stops after reaching a given state
A conversion procedure is proposed to automatically cre-
ate an actionable CPSC. See [9] for a detailed methodolog-
ical explanation of this step.
Example 1: We consider the process model given in Fig-
ure 2, formally deﬁned as a causal net by N = {A,B,C,D}
and E = {e1, e2, e3, e4, e5}. First, the conversion produces
the state chart CP = (S, V, ζ, τ) presented in Figure 2 with:
• S = {scA, s
c
B , s
c
C , s
c
D, s
w
1 , s
w
2 , s
w
3 , s
w
4 , s
w
5 } where state
sci is a care-state related to node i and state s
w
j is a
wait-state related to edge ej . Care-states refer to hospital
stays and wait-states to waiting between two stays.
• V = {(scA, s
w
1 ), (s
w
1 , s
c
B), (s
c
B , s
w
2 ), (s
w
2 , s
c
C), (s
c
B , s
w
3 ),
(sw3 , s
c
D), (s
c
C , s
w
4 ), (s
w
4 , s
c
D), (s
c
D, s
w
5 ), (s
w
5 , s
c
D)}
• ζ and τ are initialized as null (deﬁned at the 2nd step).
IV. CP STOCHASTIC SIMULATION TOOLBOX
In this Section, we provide the different elements provided
in the CP Stochastic Simulation Toolbox, including an auto-
matic setup of the simulation, validation and SA.
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Fig. 2. 1st step of the conversion procedure - initial model
sA
c s1
w sD
csB
c sc
cs2
w
s3
w
s5
w
s4
w
Fig. 3. 1st step of the conversion procedure - the output CPSC: care-states
(blue), wait-states (orange) and transitions (black)
A. Simulation setup
1) Simulation procedure: The simulation procedure for
a single entity is described as follows. First, a new entity
is created. Its initial values of features and its initial state
are drawn from the right random distributions. Then, the
procedure computes the time spent in the current state and
the next state based on the classiﬁer. This is repeated until
a stopping criterion is reached. Three stopping criteria are
used: when a state has no outgoing transition, when the
probability that a sequence stops within a given care-state
is high and when an entity’s sequence reaches the threshold
of the maximal number of care-states. This threshold is set
empirically as the size of the longest sequence seen in the
data. When an entity enters a new care-state, its features
(health condition, age, cost, medical history, etc.) are updated
accordingly. In addition, whatever the state, the entity time-
span is incremented with the time spent in this state.
2) Key Performance Indicators: Key performance indica-
tors are used for simulation model validation and to test new
situations through SA. Most KPIs are speciﬁcally chosen for
a case study. For instance, in a lung cancer care process, the
time between diagnosis and death is of major interest. Still,
based on the deﬁnition of a CPSC = (S, V, ζ, τ, p, q), we
deﬁne a set R of generic KPIs:
• KPI-1 : The total (cumulative) time spent in care-states
• KPI-2 : The total time spent in wait-states
• KPI-3 : The number of visited care-states
• KPI-4 : The number of visits in each state
A 95% conﬁdence interval is ensured when collecting such
KPIs in the toolbox. To do so, the simulation procedure is
replicated for many entities.
B. Validation
The model validation is done by comparing output values
of KPIs with the same measure from historical data. More
formally, let CPSC be a clinical pathway state chart, let
L be a log of historical patient sequences and let R =
{KPI1, . . . ,KPIn} be the set of key performance indica-
tors chosen to validate CPSC, with n ≥ 1. Then, for each
KPI we compute the absolute difference between the model
value and the data value:
δi = |KPI
CPSC
i −KPI
L
i | ∀i ∈ {1, n}
where KPICPSCi is the average value of the Monte-Carlo
replications for the KPI#i, and KPILi is the value from the
data. The simulation also produces an error value ǫi which
gives the simulation conﬁdence interval [KPICPSCi +/- ǫi].
Based on the difference δi between the model and the
data, we propose to assess the model validity with a binary
validation process: if the KPI value from the data belongs
to the simulation conﬁdence interval, we conclude that the
model is valid regarding this KPI. Formally, for each KPI
we deﬁne a validation function vi:
vi : R
2 → {0, 1}
(δi, ǫi) →
{
1 if δi ≤ ǫi
0 else
∀i ∈ {1, n} (1)
The vi function is computed for each KPI of R, thus
validating or not the model for each KPI independently.
Then, we aggregate these results to determine if the model
is globally valid. One aggregation method is to choose a
threshold on the minimum percentage of KPIs on which the
model shall be independently valid. All the KPIs not being
equally important for the validation, we introduce weighting
factors βi ∈ [0, 1] for that purpose. Let Tmin ∈ [0, 1] be
such a threshold, then a simulation model CPSC is valid if
inequality 2 stands:
n∑
i=1
βi.vi(δi, ǫi) ≥ Tmin with
n∑
i=1
βi = 1 (2)
To summarize, a new validation approach is proposed.
A binary measure against the original data is proposed on
predeﬁned KPI using a user-deﬁned validation threshold.
C. Automatic sensitivity analysis
A SA is the study of how input parameter variations
impact the model outputs. It is a technique used to determine
how an independent variable impact a dependent variable.
In this paper, we propose an automatic generation of a
SA for simulation models. First, we select eligible input
variables that may impact the model outcomes. For each
selected variable, a variation range is then determined and a
systematic SA is performed for each value of the range.
1) Automatic selection of variables to evaluate: Variables
related to clinical pathways are either care-state attributes
or instance attributes. They were used to enrich the process
model into a simulation model (instance attributes to learn
decision point choices [9], state attributes to generate random
distribution and evaluate indicators). Examples of care-state
attributes are the length of stay, the medical diagnosis and
the cost. Examples of instance attributes are age, gender and
size. Each variable is one of the 3 following types: textual,
categorical or numeric. Here, we do not consider textual
variables (e.g. medical reports). Once we have identiﬁed
these eligible variables, mainly based on the available ﬁeld
in the data set, we need to determine their variation range.
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2) Variation range of the variables: A variable variation
range depends on its type. The variation range of categor-
ical variables and of discrete numeric variables can be
determined automatically. These variables are described by
a probabilistic distribution where each probability belongs
to the interval [0 − 1] and their sum is equal to 1. An
incremental step ∆ is set based on the available computation
power (e.g. ∆ = 0.01). Then, for each possible value i of
the variable, the associated probability pi is set to 1 (other
pj = 0), and successively decreased such as pi = pi − ∆
(and pj = pj +
∆
n
).
This procedure allows to test various conﬁgurations for the
variable, without being fully exhaustive. The advantage is to
at least test high values of each pi. For a single categorical
variable with K possible values, the required number of
simulation runs for the SA is K × 1
∆
.
The variation range of a numeric continuous variable
is based on the distribution of historical data. Data are ﬁt
with the closest theoretical random distribution. The SA is
performed by shifting this distribution: the same function
(e.g. Weibull) and parameters are kept, but a translation
factor T is added. For a given variable x, based on the
standard deviation σ, the range for the translation factor T
is [−σ,+σ], with an incremental step ∆. In addition, we
use truncated random distributions for all variables with a
(semi-)bounded domain of deﬁnition (e.g. age is positive).
Finally, for any type of variable, the SA provides the
outcomes of the simulation model derived for any of the
tested input conﬁguration. An example of SA is presented in
the next Section (case study).
3) Summary: Our “automatic sensitivity analysis” de-
termines the most impacting variables on each output
measure by achieving the following: (i) Automatic selection
of variables to evaluate: modeling variables (e.g. size of the
model, conﬁdence level), and case study variables, including
care-state attributes and instance attributes; (ii) Automatic
generation of a variation range for these variables. De-
pending on their type, we developed a procedure to generate
relevant intervals; (iii) Computation of single input-output
relationship for one output KPI.
SA give decision makers new insights about the uncer-
tainties and their potential impact. It can discover hidden
input-output relationships that were not straightforward to
determine without a comprehensive model. Such information
can be used to organize an action plan with the most relevant
leverages regarding the target.
V. CASE STUDY
A. Cardiovascular diseases and implantable deﬁbrillators
Heart diseases are one of the major health problems today.
It was ranked as the ﬁrst leading cause of death in the world
in 2012 by the WHO. More speciﬁcally, cardiac arrhythmia
is the most important cause of sudden cardiac death, affecting
about 40,000 people per year in France and 300,300 in
the USA. Implantable Cardioverter Deﬁbrillators (ICDs) are
medical devices that are indicated in two cases of severe
Fig. 4. Heart failure process model
cardiac arrhythmia: after a patient has experienced sudden
death due to a ventricular tachycardia, or in prevention of it.
Data were obtained from a single source: the French
hospitalization database. It contains records of all hospital-
ization stays in France from 2006 to 2014 included, both
in public and private sectors. It is an exhaustive database
that represents 27 million hospitalization stays for 11 million
patients annually. We selected the 1,602 patients implanted in
France in 2008 and all their stays during a follow-up period
of 2-years backward (2006) and 5-years afterward (2013). It
represents a total of 16,931 hospital stays.
B. Model creation
The clinical pathway model of Figure 4 is a process model
in the form of a causal net. We uses the conversion procedure
presented in [2] to obtain a Clinical Pathway State Chart
CPSC = (S, V, ζ, τ, p, q). S and V are directly derived from
the nodes and arcs of the causal net, ζ is made of the decision
trees generated using machine learning approaches and τ was
obtained with distribution ﬁtting. The two last elements of
the CPSC are p and q. They were obtained from the historical
data and they are presented in Table I.
C. Model validation
The model was validated using the 4 Key Performance
Indicators presented in Section IV.
The results for all the KPIs are presented in Table II,
based on the simulation of 100,000 patients. Regarding KPI-
1 and KPI-2 (time related measures), the validation was
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TABLE I
STARTING AND STOPPING PROBABILITIES OF THE CP STATE CHART
Wait States Starting Stopping
probability probability
I48 (before ICD) 6.5% 0
I472 3.9% 0
I200 4.7% 0
I251 (before ICD) 11.1% 0
I422 11.0% 0
I501a 49.2% 0
Implantation 13.6% 0
Death 0 1
End of record 0 1
challenging because of the large variability of these measures
in the original data.
The simulation model seems to underestimate the time
spent by patients in care states (KPI-1) and in wait states
(KPI-2) when using the mean and the standard deviation.
However, the simulation results show a signiﬁcant decrease
in the variability (standard deviation) compared to historical
data. The high variability of the data is explained by the
presence of some outliers (e.g. a patient spent 4 years at
hospital). However, it is difﬁcult to remove outliers from the
data since these patients may bring other interesting data
to the case study. This is a difﬁculty when dealing with
health data because some individuals may carry important
information for the study. Variability reduction is an asset
for the simulation model.
TABLE II
VALIDATION RESULTS FOR 5 MEASURES (100,000 PATIENTS)
KPI Historical data Simulation model Simulation model
Mean (+/- STD) Mean (+/- STD) 95% CI
KPI #1 65.80 days (+/-
88.10)
45.07 (+/- 29.18) +/- 0.15
KPI #2 4 years 1 month 3 years 8 months +/- 1.55 days
(+/- 2 years 1
month)
(+/- 9 months)
KPI #3 13.2 care states
(+/-18.8)
11.7 (+/- 4.8) +/- 0.025
KPI #4 Figure 5 68.5% -
Regarding KPI-3, we obtained a close value of the number
of care states in a trace sequence (11.7 versus 13.2). KPI-4
is presented in detail in Figure 5. For each care state, the
histogram shows the historical data (orange), the simulation
result (blue) and the 95% conﬁdence interval (red line).
Based on a binary validation approach, the simulation model
gets a validation score of 68.5% for KPI-4, which is above
regular thresholds (50% or 66% for binary validation).
D. Sensitivity analysis
An automatic SA of input parameters was then performed
for the simulation model described above, as described in
Section IV. The input parameters are the patient features
available in the case study data. It includes the 5 comor-
bidities, 2 non-medical patient characteristics and 1 variable
related to deﬁbrillators: (1) Hypertension, (2) Diabetes, (3)
Fig. 5. Validation of the CPSC on KPI#4. States legend: 0 (implantation), 1
(end of record), 2 (I501a), 3 (I501b), 4 (death), 5 (I200), 6 (Z450), 7 (I420),
8 (Z098), 9 (I422), 10 (I251), 11 (I48-before), 13 (I472), 14 (I48-after), 25
(Z514), 57 (R570)
Obesity, (4) Kidney failure, (5) Cancer, (6) Age at implan-
tation, (7) Gender and (8) Replacement rate.
Figure 6 shows the result of the sensitivity analysis on
KPI-1, the total time spent by patients in care-states. The
impact of the 8 input variables is displayed on the same
graph (8 curves), even if each variable varies independently
(anything else equal). The y-axis represents the possible
values of KPI-1 and the x-axis represents variations on the
input variables. In order to plot and to easily compare the 8
curves, we normalized the possible values of each variable.
The baseline point is when the modiﬁcation coefﬁcient of all
variables is 1 (Green Arrow).
Among the 8 inputs, only 2 inﬂuence the time spent by
patients in care-states: the age at implantation (red line) and
the presence of kidney (grey line) failure. First, the impact
of kidney failure is linear. The fewer patients have kidney
failure (caution, a high coefﬁcient of this variable means
fewer patients), the shorter the total time spent in care-states
(i.e. at hospital) will be. It can be explained by the necessity
of having regular dialyses sessions (half a day) when having
kidney failure. Regarding the age at implantation, the curve’s
shape appears more atypical. From the left, there is a fast
increase in KPI-1 when the implantation age increases, then
it stagnates, and it ﬁnally slowly decreases. This shape
illustrates the fact that an increase in age is totally correlated
with the need for more cares (the initial increase). After a
certain threshold (mean age at implantation is 75), need for
care on a 4-year term decreases because patients die faster.
Figure 7 shows the result of the sensitivity analysis on
KPI-4, the number of times that state cardiomyopathy before
implantation was visited by a patient. The outcome values are
standardized for 1,602 patients. For this KPI, it is interesting
to notice that no input variable signiﬁcantly impacts the
output values. It means that such cardiac issues are not de-
pendent on factors that we incorporated in the model. A more
in-depth backward analysis of patient history might turn out
more relevant (more than 2 years before implantation).
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Similarly to the previous graph, Figure 8 shows the result
of the sensitivity analysis on KPI-4, the number of times
that state cardiomyopathy after implantation was visited
by a patient. This time, two input variables show a direct
impact on the output values: the age at implantation and
the replacement rate. An increase in the age of patients
when being implanted induces a substantial decrease in the
number of times they have a cardiomyopathy (red line). This
is probably explained by an edge effect of the long-term
follow up of patients (4-5 years). Older patients with severe
heart conditions have “less time” to develop other issues as
the 2-year death rate is extremely high for patients over 75.
Regarding the replacement rate, an increase (i.e. more
patients have a deﬁbrillator replacement after few years)
induces a linear decrease in the risk of having a cardiomyopa-
thy (green line). It shows the importance of a close follow-up
of patients and of anticipating the device malfunctioning.
VI. CONCLUSIONS
In this paper, we proposed the ﬁnal phase of a formal
procedure for the automatic conversion of a process model
discovered from a health database into a simulation model.
Our objective was to be able to generate new patients
that are close enough to the historical data. We used the
concept of state charts to integrate several perspectives of
clinical pathways into a single simulation model. After the
Age at implantation
Replacement rate
Replacement, mean
Replacement, upper CI
Replacement, lower CI
Gender, mean
Gender, upper CI
Gender, lower CI
Implantation age, mean
Implantation age, upper CI
Implantation age, lower CI
Hypertension, mean
Hypertension, upper CI
Hypertension, lower CI
Diabetes, mean
Diabetes, upper CI
Diabetes, lower CI
Obesity, mean
Obesity, upper CI
Obesity, lower CI
Kidney failure, mean
Kidney failure, upper CI
Kidney failure, lower CI
Cancer, mean
Cancer, upper CI
Cancer, lower CI
Impact of the input parameters on KPI-4 (cardiomyopathy after)
N
u
m
b
e
r 
o
f 
ti
m
e
s 
in
 t
h
e
 c
a
re
-s
ta
te
Parameter variations (modification coefficient)
Baseline
Fig. 8. SA: impact of 8 input variables on KPI-4 (b)
simulation model creation, we introduced several generic key
performance indicators that can be used for model validation.
We run the model to simulate the pathway of new patients
so that we compare the output KPIs with the historical
values from the event log. A validated model is ﬁnally
used to perform sensitivity analysis and what-if scenarios
evaluation. Sensitivity analysis provides insights about the
determinant factors (input variables) that most impact the
model’s behavior (output measures). The resulting toolbox is
a “ready-to-use” software for health practitioners. For future
works, we plan to integrate resources in the model which
means a deep modiﬁcation of the simulation procedure since
patients will be linked together. A further analysis of the new
complexity of such update will be required. Also, we plan
on creating a loop in order to automatically clean health
data by removing outliers from the original data. Finally,
an extension to multi-way sensitivity analysis may be an
interesting contribution for practitioners.
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